Development of a radiotherapy adherence model for patients with breast cancer: A cross-sectional study at a tertiary referral hospital in Indonesia
Archive of Oncology · 2026 · (00) · 6-6
DOI: 10.2298/aoo260826006k ↗Abstract
Background: Adherence to radiotherapy is an essential factor in treatment success among patients with breast cancer. However, physical and psychological side effects often result in patients discontinuing therapy before completion. Social support and resilience are also considered to play important roles in maintaining adherence. Objective: This study aimed to develop a radiotherapy adherence model based on physical and psychological side effects, social support, and resilience among patients with breast cancer at a hospital in Banjarmasin, Indonesia. Methods: A quantitative cross-sectional study was conducted in 100 breast cancer patients undergoing radiation therapy, with each group comprising 50 patients. Participants were recruited using consecutive sampling. Study variables, consisting of physical and psychological side effects, social support, resilience, and radiotherapy adherence, were measured using adapted questionnaires based on the RTOG Acute Radiation Morbidity Criteria, EORTC QLQ-C30, MSPSS, and CD-RISC. Data were analyzed using descriptive statistics and PLS-SEM. Results: Physical and psychological side effects were negatively associated with adherence, whereas social support and resilience were positively associated with adherence. Resilience emerged as the strongest factor associated with adherence and acted as the mediator connecting treatment side effects and social support with adherence. Conclusion: Adherence is associated with the interaction of physical and psychological side effects, social support, and resilience. Resilience plays a central protective role in maintaining adherence and mediating the impacts of side effects and social support. The model developed in this study may provide a foundation for designing interventions and oncology care to improve adherence to radiation therapy in breast cancer patients.
EUVIMED